Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $107.10 --0%
Revenue Growth %: +7.2%
Financial Fact:
Total revenues: 374.18M
Today's EPS Names:
ESCA, LICT, NKSH, More
Revenue Growth %: +7.2%
Financial Fact:
Total revenues: 374.18M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- F.N.B. Corp (FNB) Reports In-Line Q1 EPS
- Kinder Morgan (KMI) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
